Anbio Biotechnology Shareholders' Equity
Anbio Biotechnology (NNNN) had Shareholders' Equity of $30.16 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-04-07
- 2025-12-31: Stockholders' Equity Attributable to Parent $30.16M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $17.19M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $14.82M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $12.55M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | $30.16M 20-F · filed 2026-04-07 |
| 2024-12-31 | $17.19M 20-F · filed 2026-04-07 |
| 2023-12-31 | $14.82M 20-F · filed 2026-04-07 |
| 2022-12-31 | $12.55M 20-F · filed 2026-04-07 |